Effect of staurosporine on cycle of human gastric cancer cells

World Journal of Gastroenterology

Volumn 10, Issue 2, 2004, Pages 161-166

  Ha, Min Wen ^a   Hou, Ke Zuo ^a   Liu, Yun Peng ^a   Yuan, Yuan ^a  

^a 1st Affiliated Hospital of China Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; ENZYME INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN P21; STAUROSPORINE; TRYPAN BLUE;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIVISION; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; METABOLISM; MITOSIS; MITOSIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH TUMOR; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; UPREGULATION;

EID: 1042292695     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i2.161     Document Type: Article

References (32)

1. Caponigro F, French RC, Kaye SB. Protein Kinase C: A worth-while target for anticancer drugs? Anticancer Drugs 1997; 8: 26-33
2. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997; 46: 1473-1480
3. Toledo LM, Lydon NB, Elbaum D. The structure-based design of ATP-site directed protein kinase inhibitors. Curr Med Chem 1999; 6: 775-805
4. Zaugg K, Rocha S, Resch H, Hegyi I, Oehler C, Glanzmann C, Fabbro D, Bodis S, Pruschy M. Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412. Cancer Res 2001; 61: 732-738
5. Gescher A. Analogs of staurosporine: Potential anticancer drugs? Gen Pharmacol 1998; 31: 721-728
6. Xia M, Xue SB, Xu CS. Shedding of TNFR1 in regenerative liver can be induced with TNF alpha and PMA. World J Gastroenterol 2002; 8: 1129-1133
7. Li MS, Li PF, He SP, Du GG, Li G. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World J Gastroenterol 2002; 8: 469-475
8. Ouyang GL, Li QF, Peng XX, Liu QR, Hong SG. Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells. World J Gastroenterol 2002; 8: 1053-1058
9. Han Y, Han ZY, Zhou XM, Shi R, Zheng Y, Shi YQ, Miao JY, Pan BR, Fan DM. Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines. World J Gastroenterol 2002; 8: 441-445
10. Gescher A. Staurosporine analogues - Pharmacological toys or useful antitumor agents? Crit Rev Oncol Hematol 2000; 34: 127-135
11. Chen B, He L, Savell VH, Jenkins JJ, Parham DM. Inhibition of the interferon-γ/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res 2000; 60: 3290-3298
12. Zeng YX, El-Deiry WS. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 1996; 12: 1557-1564
13. Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, McClanahan T, Black S, Rizzi G, Musco ML, Mirza A, Liu S. Transcriptional regulation during p21WAF1/CIP1 induced apoptosis in human ovarian cancer cells. J Biol Chem 2002; 277: 36329-36337
14. Kovalsky O, Lung FD, Roller PP, Fornace Jr. AJ Oligomerization of human Gadd45a protein. J Biol Chem 2001; 276: 39330-39339
15. Mihalik R, Uher F, Pocsik EE, Berczi L, Benczur M, Kopper L. Detection of drug-induced apoptosis by flow cytometry after alkaline extraction of ethanol fixed cells. Pathol Oncol Res 1996; 2: 78-83
16. Heerdt BG, Houston MA, Mariadason JM, Augenlicht LH. Dissociation of staurosporine-induced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: Initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential(deltapsim). Cancer Res 2000; 60: 6704-6713
17. Salvioli S, Dobrucki J, Moretti L, Troiano L, Fernandez MG, Pinti M, Pedrazzi J, Franceschi C, Cossarizza A. Mitochondrial heterogeneity during staurosporine-induced apoptosis in HL60 cells: Analysis at the single cell and single organelle level. Cytometry 2000; 40: 189-197
18. He SW, Shen KQ, He YJ, Xie B, Zhao YM. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma. World J Gastroenterol 1999; 5: 408-416
19. Bernard B, Fest T, Pretet JL, Mougin C. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle. Cell Death Differ 2001; 8: 234-244
20. Stokke T, Smedshammer L, Jonassen TS, Blomhoff HK, Skarstad K, Steen HB. Uncoupling of the order of the S and M phases: Effects of staurosporine on human cell cycle kinases. Cell Prolif 1997; 30: 197-218
21. Zeng ZC, Jiang GL, Wang GM, Tang ZY, Curran WJ, Iliakis G. DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line. World J Gastroenterol 2002; 8: 797-803
22. Bertrand R, Solary E, O'Connor P, Kohn KW, Pommier Y. Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res 1994; 211: 314-321
23. Fang JY, Lu YY. Effects of histone acetylation and DNA methylation on p21(WAF1) regulation. World J Gastroenterol 2002; 8: 400-405
24. Wartenberg M, Fischer K, Hescheler J, Sauer H. Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors. Biochim Biohys Acta 2002; 1589: 49-62
25. Yuste VJ, Sanchez-Lopez I, Sole C, Encinas M, Bayascas JR, Boix J, Comella JX. The prevention of the staurosporine-induced apoptosis by Bcl-X(L), but not by Bcl-2 or caspase inhibitors, allows the extensive differentiation of human neuroblastoma cells. J Neurochem 2002; 80: 126-139
26. Shimizu T, Takahashi N, Tachibana K, Takeda K. Complex regulation of CDK2 and G1 arrest during neuronal differentiation of human prostatic cancer TSU-Prl cells by staurosporine. Anticancer Res 2001; 21: 893-898
27. Narita Y, Asai A, Kuchino Y, Kirino T. Actinomycin D and staurosporine, potent apoptosis inducers in vitro, are potentially effective chemotherapeutic agents against glioblastoma multiforme. Cancer Chemother Pharmacol 2000; 45: 149-156
28. Chen X, Lowe M, Herliczek T, Hall MJ, Danes C, Lawrence DA, Keyomarsi K. Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrest. J Natl Cancer Inst 2000; 92: 1999-2008
29. Sausville EA, Johnson J, Alley M, Zaharevitz D, Senderowicz AM. Inhibition of CDKs as a therapeutic modality. Ann N Y Acad Sci 2000; 910: 207-221
30. Shchepina LA, Popova EN, Pletjushkina OY, Chernyak BV. Respiration and mitochondrial membrane potential are not required for apoptosis and anti-apoptotic action of Bcl-2 in HeLa cells. Biochemistry 2002; 67: 222-226
31. Swe M, Sit KH. Staurosporine induces telophase arrest and apoptosis blocking mitosis exit in human Chang liver cells. Biochem Biophys Res Commun 1997; 236: 594-598
32. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S, Schulze-Osthoff K. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 2001; 20: 1193-1202